What’s Missing from ICER’s Assessment of Abuse-Deterrent Opioids
Abuse-deterrent formulations (ADF) of opioids resist crushing or dissolving for misuse, helping to curb widespread opioid abuse.
But a recent report from the Institute for Clinical and Economic Review underestimates ADFs’ value by ignoring several key benefits.
Feedback on ICER’s Abuse Deterrent Formulations of Opioids: Effectiveness and Value report
ICER’s report on opioid ADFs lays out several important facts. First, pain is a significant medical problem with potentially devastating costs for patients, particularly for chronic pain patients. Second, opioids can be a valuable medicine for pain patients, but they also present certain risks. And third, ADF opioids are an emerging technology that can help […]
How Balanced Treatment, Innovation & Better Policy Can Help Solve the Opioid Epidemic
“Doctor, make my pain go away.” I hear this plea, in one form or another, from patients on a daily basis. Yet it presents physicians like me with a troubling conundrum.
